Bryan Supran sold $399K of Alnylam Pharmaceuticals stock
By AlphaYouPublished Form 4
SUPRAN BRYAN
Reporting filer
Bryan Supran reported selling 1,758 shares of Alnylam Pharmaceuticals, Inc. for about $399K ($226.88 a share on average). Form 4 filed Oct 6, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Oct 6, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | SUPRAN BRYAN | 2026-10-02 | S | Sale | 1758 | 226.88 | 12,807 | 4 days | Filed terms
|
Common Stock
- Owner
- SUPRAN BRYAN
- Date
- 2026-10-02
- Code
- S
- Action
- Sale
- Quantity
- 1758
- Price
- 226.88
- Following holdings
- 12,807
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-02
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Timeliness:
- transaction Shares: 1758
- transaction Price Per Share: 226.88
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 12807
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- SUPRAN BRYAN: EVP, CLO and Secretary.
- F1: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units.
Original sources
Prepared automatically from public filing data. Report a correction.